Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 10, 2024Family Medicine and Primary Care Open AccessOpen Access

The Role of SGLT2 Inhibitors on Treatment of Heart Failure, Mode of Actions

View Full Paper
Ask AI
Bookmark
Share

Authors

RARaid M. Al AboodDADunia Al-Naemi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abood et al. (2024) studied this question.

synapsesocial.com/papers/68e6ab39b6db64358762deaahttps://doi.org/10.29011/2688-7460.100257
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New insights into the molecular mechanisms of SGLT2 inhibitors on ventricular remodeling2023 · 23 citations
  2. 2Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease2020 · 68 citations
  3. 3Left Ventricular Remodeling Response to SGLT2 inhibitors in Heart Failure: An Updated Meta-analysis of Randomized Controlled Studies2023 · 4 citations
  4. 4Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial2021 · 38 citations
  5. 5The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease2020 · 66 citations